Laurus Labs Limited (LAURUSLABS) - Total Liabilities

Latest as of September 2025: Rs44.82 Billion INR ≈ $484.68 Million USD

Based on the latest financial reports, Laurus Labs Limited (LAURUSLABS) has total liabilities worth Rs44.82 Billion INR (≈ $484.68 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Laurus Labs Limited net asset momentum to track the company's year-over-year net asset growth rate.

Laurus Labs Limited - Total Liabilities Trend (2013–2025)

This chart illustrates how Laurus Labs Limited's total liabilities have evolved over time, based on quarterly financial data. See Laurus Labs Limited (LAURUSLABS) free cash flow to measure how efficiently the company converts operating cash flow to free cash.

Laurus Labs Limited Competitors by Total Liabilities

The table below lists competitors of Laurus Labs Limited ranked by their total liabilities.

Company	Country	Total Liabilities
BrightSpring Health Services, Inc. Common Stock NASDAQ:BTSG	USA	$4.22 Billion
Shenzhen Transsion Holdings Co Ltd SHG:688036	China	CN¥26.32 Billion
SouthState Corporation NYSE:SSB	USA	$58.14 Billion
Lynas Rare Earths Limited F:LYIC	Germany	€591.51 Million
Sunoco LP NYSE:SUN	USA	$12.30 Billion
Pentair plc F:PNT	Germany	€3.26 Billion
Figma, Inc. NYSE:FIG	USA	$837.57 Million
U-Haul Holding Company NYSE:UHAL-B	USA	$14.40 Billion

Liability Composition Analysis (2013–2025)

This chart breaks down Laurus Labs Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Laurus Labs Limited (LAURUSLABS) market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.32	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	0.02	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.93	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.48	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Laurus Labs Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Laurus Labs Limited (2013–2025)

The table below shows the annual total liabilities of Laurus Labs Limited from 2013 to 2025.

Year	Total Liabilities	Change
2025-03-31	Rs47.33 Billion ≈ $511.86 Million	+10.81%
2024-03-31	Rs42.71 Billion ≈ $461.94 Million	+18.27%
2023-03-31	Rs36.12 Billion ≈ $390.60 Million	+0.08%
2022-03-31	Rs36.09 Billion ≈ $390.30 Million	+14.57%
2021-03-31	Rs31.50 Billion ≈ $340.66 Million	+59.05%
2020-03-31	Rs19.81 Billion ≈ $214.19 Million	+11.72%
2019-03-31	Rs17.73 Billion ≈ $191.72 Million	+15.56%
2018-03-31	Rs15.34 Billion ≈ $165.91 Million	+15.96%
2017-03-31	Rs13.23 Billion ≈ $143.07 Million	-8.84%
2016-03-31	Rs14.51 Billion ≈ $156.94 Million	+29.36%
2015-03-31	Rs11.22 Billion ≈ $121.32 Million	+22.63%
2014-03-31	Rs9.15 Billion ≈ $98.93 Million	+105.95%
2013-03-31	Rs4.44 Billion ≈ $48.04 Million	--

About Laurus Labs Limited

NSE:LAURUSLABS India Drug Manufacturers - Specialty & Generic

Market Cap

$10.58 Billion

Rs977.90 Billion INR

Market Cap Rank

#2128 Global

#91 in India

Share Price

Rs1811.40

Change (1 day)

-0.26%

52-Week Range

Rs821.85 - Rs1816.20

All Time High

Rs1816.20